AMTI — Applied Molecular Transport. Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $11.01m
- -$7.10m
Annual income statement for Applied Molecular Transport., fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 29.9 | 28.3 | 66.7 | 101 | 127 |
| Operating Profit | -29.9 | -28.3 | -66.7 | -101 | -127 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -29.9 | -28 | -66.6 | -100 | -126 |
| Net Income After Taxes | -29.9 | -28 | -66.6 | -100 | -126 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -29.9 | -28 | -66.6 | -100 | -126 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -29.9 | -28 | -66.6 | -100 | -126 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.922 | -0.866 | -2.91 | -2.67 | -3.25 |
| Dividends per Share |